StreetInsider.com News Articles

Form 8-K Cronos Group Inc. For: Oct 15

Thu, 15 Oct 2026 07:02:00 -0400

si-local-file:///var/storage/secattach/20261015/27189507.html

Cronos buys Dutch cannabis firm CanAdelaar for €57.5M

Thu, 15 Oct 2026 07:00:50 -0400

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has completed its acquisition of CanAdelaar B.V., a cannabis company operating within the Netherlands' government-led adult-use cannabis pilot program known as the Wietexperiment, for a base purchase price of €57.5 million, subject to closing and post-closing adjustments.

The deal, originally announced December 9, 2025, also includes contingent cash consideration equal to 0.5x CanAdelaar's Normalized EBITDA for each of 2026 and 2027. The base purchase price represents approximately 1.4x net revenue and 2.9x Adjusted EBITDA based on first-half 2026 annualized figures, according to the company.

CanAdelaar is headquartered in Voorne aan Zee, Netherlands, and operates a

Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company

Thu, 15 Oct 2026 07:00:00 -0400

Cronos acquires CanAdelaar for a base purchase price of €57.5 million plus cash earnout of 0.5x Normalized EBITDA¹ in 2026 and 2027

Establishes Cronos’ European platform with #1 market share² in the largest adult-use cannabis market in Europe³

Enables borderless product strategy, leveraging investments in genetics, R&D, and product development

TORONTO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabis company, today announced that it has completed its previously announced acquisition of CanAdelaar B.V. (“CanAdelaar”), the largest cannabis company operating

Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company

Thu, 15 Oct 2026 07:00:00 -0400

Cronos acquires CanAdelaar for a base purchase price of €57.5 million plus cash earnout of 0.5x Normalized EBITDA¹ in 2026 and 2027

Establishes Cronos’ European platform with #1 market share² in the largest adult-use cannabis market in Europe³

Enables borderless product strategy, leveraging investments in genetics, R&D, and product development

Zuanic and Associates Starts Cronos Group (CRON) at Overweight

Tue, 13 Oct 2026 08:23:09 -0400

Zuanic and Associates analyst Pablo Zuanic initiates coverage on Cronos Group (NASDAQ: CRON) with a Overweight rating.

The analyst comments "We initiate equity research coverage of Cronos Group (US NASDAQ: CRON; TSX: CRON) with an Overweight rating. Cronosis a founder led cannabis company, with a long-term focus on accretive earnings growth (EBITDA/cash flow positive; accretive deal making), supply chain and distribution driven (but no retail), and backed by Altria (42% equity stake; CRON will be MO’s only investment vehicle in cannabis). With a ~$1Bn war chest (cash and investments), Cronos is well-placed to act as the industry consolidates. Cronos has shown

Zuanic and Associates Starts Cronos Group (CRON) at Overweight

Tue, 13 Oct 2026 08:23:09 -0400

Zuanic and Associates analyst Pablo Zuanic initiates coverage on Cronos Group (NASDAQ: CRON) with a Overweight rating.

Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season

Tue, 13 Oct 2026 07:30:00 -0400

TORONTO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that for the third consecutive year it is bringing back its popular limited-edition Caramel Green Apple flavor to its best-selling lineup of SOURZ by Spinach^® edibles. For the first time, this seasonal flavor will launch exclusively in the SOURZ by Spinach^® Fully Blasted 10-pack, the #1 edible multipack in Canada¹.

The brand is also welcoming back the popular Spinach^® Sweet Green Apple 1g vape that first launched in 2025. This limited-edition flavor bolsters a best-selling

Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season

Tue, 13 Oct 2026 07:30:00 -0400

The brand is also welcoming back the popular Spinach^® Sweet Green Apple 1g vape that first launched in 2025. This limited-edition flavor bolsters a best-selling

Cronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026

Thu, 08 Oct 2026 07:30:00 -0400

TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 third quarter earnings conference call on Thursday, November 5, 2026, at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast

Cronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026

Thu, 08 Oct 2026 07:30:00 -0400

Can Cronos turn production and brand power into a bigger cannabis comeback?

Mon, 28 Sep 2026 10:12:44 -0400

Investing.com -- Cronos Group’s manufacturing capacity, cannabis genetics and branded product portfolio are drawing renewed attention after the company showcased its operations at an investor day, prompting an analyst to raise its 12-month price target to C$5.50 from C$5.25.

The investor day highlighted Cronos’ full utilization of its large-scale GrowCo facility, a genetics platform focused on yield and product quality, and a "Hero" brand strategy that has helped it build significant market share in Canada and Israel. The analyst said the operational strengths challenge a market view that focuses primarily on Cronos’ cash position rather than its cannabis

Can Cronos turn production and brand power into a bigger cannabis comeback?

Mon, 28 Sep 2026 10:12:44 -0400

Cronos Group (CRON:CN) (CRON) PT Raised to Cdn$7 at TD Securities

Mon, 28 Sep 2026 08:13:03 -0400

TD Securities analyst Derek Lessard raised the price target on Cronos Group (CRON:CN) (NASDAQ: CRON) to Cdn$7.00 (from Cdn$6.00) while maintaining a Buy rating.

Cronos Group (CRON:CN) (CRON) PT Raised to Cdn$7 at TD Securities

Mon, 28 Sep 2026 08:13:03 -0400

TD Securities analyst Derek Lessard raised the price target on Cronos Group (CRON:CN) (NASDAQ: CRON) to Cdn$7.00 (from Cdn$6.00) while maintaining a Buy rating.

Cronos Group (CRON:CN) (CRON) PT Raised to Cdn$7 at TD Securities

Mon, 28 Sep 2026 08:13:03 -0400

TD Securities analyst Derek Lessard raised the price target on Cronos Group (CRON:CN) (NASDAQ: CRON) to Cdn$7.00 (from Cdn$6.00) while maintaining a Buy rating.

Cronos Group (CRON:CN) (CRON) PT Raised to Cdn$7 at TD Securities

Mon, 28 Sep 2026 08:13:03 -0400

TD Securities analyst Derek Lessard raised the price target on Cronos Group (CRON:CN) (NASDAQ: CRON) to Cdn$7.00 (from Cdn$6.00) while maintaining a Buy rating.

Cronos Group (CRON:CN) (CRON) PT Raised to Cdn$5.50 at Canaccord

Mon, 28 Sep 2026 07:06:07 -0400

Canaccord analyst Kenric Tyghe raised the price target on Cronos Group (CRON:CN) (NASDAQ: CRON) to Cdn$5.50 (from Cdn$5.25) while maintaining a Buy rating.

Cronos Group (CRON:CN) (CRON) PT Raised to Cdn$5.50 at Canaccord

Mon, 28 Sep 2026 07:06:07 -0400

Canaccord analyst Kenric Tyghe raised the price target on Cronos Group (CRON:CN) (NASDAQ: CRON) to Cdn$5.50 (from Cdn$5.25) while maintaining a Buy rating.

Cronos Group (CRON:CN) (CRON) PT Raised to Cdn$5.50 at Canaccord

Mon, 28 Sep 2026 07:06:07 -0400

Canaccord analyst Kenric Tyghe raised the price target on Cronos Group (CRON:CN) (NASDAQ: CRON) to Cdn$5.50 (from Cdn$5.25) while maintaining a Buy rating.

Cronos Group (CRON:CN) (CRON) PT Raised to Cdn$5.50 at Canaccord

Mon, 28 Sep 2026 07:06:07 -0400

Canaccord analyst Kenric Tyghe raised the price target on Cronos Group (CRON:CN) (NASDAQ: CRON) to Cdn$5.50 (from Cdn$5.25) while maintaining a Buy rating.

Cronos Hosts 2026 Investor Day

Thu, 24 Sep 2026 08:00:00 -0400

TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, is hosting its first Investor Day today, September 24, 2026, at its Cronos Growing Company Inc. Kingsville location.

Presentation materials can be accessed on the Company’s Investor Relations website under Events & Presentations at: https://ir.thecronosgroup.com/events-presentations

The session will be webcast today starting at 12:00 p.m. ET. Webcast registration is now open at: https://dpregister.com/sreg/10211885/104dd78be04.

After the event, a recording of the webcast will be archived for replay on the Company’s

Cronos Hosts 2026 Investor Day

Thu, 24 Sep 2026 08:00:00 -0400

The session will be webcast today starting at 12:00 p.m. ET. Webcast registration is now open at: https://dpregister.com/sreg/10211885/104dd78be04.

After the event, a recording of the webcast will be archived for replay on the Company’s

Cronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario

Tue, 15 Sep 2026 16:15:00 -0400

Registration is now open for Cronos’ first Investor Day, which will be hosted by the Cronos Leadership Team, on September 24, 2026

TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, will host its first Investor Day on Thursday, September 24, 2026, at its Growing Company (“Cronos GrowCo”) Kingsville location.

“We’re excited to host our first Cronos Investor Day from our Kingsville, Ontario, Cronos GrowCo location. This facility is at the center of how we’ve been scaling production, driving efficiency, and building the product pipeline that’s fueling

Cronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario

Tue, 15 Sep 2026 16:15:00 -0400

Registration is now open for Cronos’ first Investor Day, which will be hosted by the Cronos Leadership Team, on September 24, 2026

Cronos Group extends cannabis acquisition deadline to October 2026

Fri, 11 Sep 2026 16:34:48 -0400

Cronos Group Inc. (NASDAQ: CRON) has amended its share purchase agreement related to the planned acquisition of CanAdelaar B.V., a licensed cannabis grower participating in the Dutch Controlled Cannabis Supply Chain Experiment.

According to a company statement, the amendment extends the Long Stop Date of the agreement from September 9, 2026, to October 15, 2026. The deal involves Cronos Group's indirect wholly owned subsidiary, CGM B.V., acquiring all issued and outstanding shares of CanAdelaar B.V. from sellers "Ring" International Holding AG and Landewyck Tobacco S.A.

CanAdelaar B.V. is one of ten licensed cannabis growers in the Dutch Controlled Cannabis Supply Chain Experiment.